USA - NYSE:CL - US1941621039 - Common Stock
The current stock price of CL is 78.44 USD. In the past month the price decreased by -1.58%. In the past year, price decreased by -17.96%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PG | PROCTER & GAMBLE CO/THE | 22.29 | 356.25B | ||
| KMB | KIMBERLY-CLARK CORP | 17.24 | 39.40B | ||
| CHD | CHURCH & DWIGHT CO INC | 25.43 | 21.12B | ||
| CLX | CLOROX COMPANY | 15.05 | 14.17B | ||
| REYN | REYNOLDS CONSUMER PRODUCTS I | 14.5 | 4.91B | ||
| WDFC | WD-40 CO | 35.55 | 2.79B | ||
| CENT | CENTRAL GARDEN & PET CO | 12.04 | 1.99B | ||
| CENTA | CENTRAL GARDEN AND PET CO-A | 10.9 | 1.80B | ||
| ENR | ENERGIZER HOLDINGS INC | 7.34 | 1.67B | ||
| SPB | SPECTRUM BRANDS HOLDINGS INC | 14.14 | 1.34B | ||
| ODC | OIL-DRI CORP OF AMERICA | 12.66 | 895.09M |
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. The company is headquartered in New York City, New York and currently employs 34,000 full-time employees. The company is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
COLGATE-PALMOLIVE CO
300 Park Ave
New York City NEW YORK 10022 US
CEO: Noel R. Wallace
Employees: 34000
Phone: 12123102000
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. The company is headquartered in New York City, New York and currently employs 34,000 full-time employees. The company is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
The current stock price of CL is 78.44 USD. The price decreased by -1.78% in the last trading session.
COLGATE-PALMOLIVE CO (CL) has a dividend yield of 2.66%. The yearly dividend amount is currently 2.19.
CL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
The Revenue of COLGATE-PALMOLIVE CO (CL) is expected to grow by 0.9% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
COLGATE-PALMOLIVE CO (CL) has a market capitalization of 63.40B USD. This makes CL a Large Cap stock.
The outstanding short interest for COLGATE-PALMOLIVE CO (CL) is 1.56% of its float.
ChartMill assigns a fundamental rating of 6 / 10 to CL. While CL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months CL reported a non-GAAP Earnings per Share(EPS) of 3.65. The EPS increased by 4.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.55% | ||
| ROA | 16.65% | ||
| ROE | 414.39% | ||
| Debt/Equity | 10.18 |
29 analysts have analysed CL and the average price target is 96.43 USD. This implies a price increase of 22.93% is expected in the next year compared to the current price of 78.44.
For the next year, analysts expect an EPS growth of 5.51% and a revenue growth 0.9% for CL